You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 5,935,607

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,935,607

Title:	Treatment of osteoporosis
Abstract:	A method of treating osteoporosis is disclosed by administering orally a single daily dosage of phosphate in the evening in an amount, e.g., about 10 mg/kg body weight or less which is effective to raise serum parathyroid hormone levels of the subject being treated.
Inventor(s):	Silver; Justin (Motza Ilit, IL)
Assignee:	Hadasit Medical Research Services and Development Company Ltd. (Jerusalem, IL)
Application Number:	08/601,989
Patent Claims:	1. A method of treating osteoporosis in a human or other animal subject comprising the step of orally administering to said subject a single daily dose of a composition consisting essentially of phosphoric acid or phosphate, prior to bedtime in the evening or night, said oral dose being about 10 mg/kg body weight per day, or less, which is effective to raise serum parathyroid hormone levels. 2. The method according to claim 1, wherein said effective amount of phosphate is about 1000 mg, or less. 3. The method according to claim 1, wherein said treatment restores the subject's circadian rhythm. 4. The method according to claim 1, comprising the additional step of administering to the subject during the daytime an auxiliary agent which decreases the subject's serum parathyroid hormone level. 5. The method of claim 2 comprising the additional step of administering to the subject during the daytime an auxiliary agent which decreases the subject's serum parathyroid hormone level. 6. The method according to claim 4, wherein said auxiliary agent is calcium. 7. The method according to claim 5, wherein said auxiliary agent is calcium. 8. The method of claim 1, wherein said phosphate is selected from the group consisting of sodium phosphate, and potassium phosphate.

Details for Patent 5,935,607

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2039-02-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.